← Emergent BioSolutions Inc.
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||
| Net Income (Loss) Attributable to Parent | $51.8m | $82.6m | $62.7m | $54.5m | $305.1m | $230.9m | ($211.6m) | ($760.5m) | ($190.6m) | $52.6m | |
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | $51.8m | — | $62.7m | — | — | — | — | — | — | — | |
| Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | $62.5m | $82.6m | $62.7m | — | — | — | — | — | — | — | |
| Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | ($10.7m) | $0 | $0 | — | — | — | — | — | — | — | |
| Depreciation, Depletion and Amortization | $28.0m | $32.2m | $36.3m | $49.5m | $50.1m | $123.8m | $143.3m | $125.1m | $108.8m | $95.8m | |
| Depreciation | $38.2m | $42.6m | $62.2m | $110.7m | $114.5m | $62.2m | $83.4m | $59.5m | $43.7m | $30.7m | |
| Amortization of Debt Issuance Costs | $781k | $681k | ($13.4m) | $3.0m | $3.5m | $4.1m | $4.1m | $21.3m | $7.4m | $9.8m | |
| Amortization of Intangible Assets | $6.9m | $8.6m | $25.0m | $58.7m | $59.8m | $58.5m | $59.9m | $65.6m | $65.1m | $65.1m | |
| Deferred Income Tax Expense (Benefit) | $5.2m | $3.3m | $8.6m | ($1.1m) | ($2.4m) | $43.9m | ($33.7m) | ($7.3m) | ($5.5m) | ($3.9m) | |
| Share-based Payment Arrangement, Noncash Expense | $18.5m | $15.2m | $23.2m | $26.7m | $51.0m | $42.4m | $45.1m | $23.1m | $18.0m | $16.2m | |
| Payment, Tax Withholding, Share-based Payment Arrangement | — | $4.3m | $6.6m | $7.4m | $13.8m | $13.8m | $5.9m | $2.5m | $1.2m | $1.4m | |
| Share-based Payment Arrangement, Expense | $18.5m | $15.2m | $23.2m | $26.7m | $51.0m | $42.4m | $45.1m | $23.1m | $18.0m | $16.2m | |
| Goodwill, Impairment Loss | — | — | — | $0 | $0 | $41.7m | $6.7m | $218.2m | $0 | $0 | |
| Impairment of Intangible Assets, Finite-lived | — | — | — | $12.0m | $29.0m | — | — | — | — | — | |
| Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) | $701k | $0 | — | — | — | $41.7m | $6.7m | — | — | — | |
| Gain (Loss) on Disposition of Assets | — | — | — | — | — | — | — | — | ($28.7m) | ($4.5m) | |
| Gain (Loss) on Disposition of Business | — | — | — | — | — | — | — | $74.2m | $24.3m | $0 | |
| Gain (Loss) on Extinguishment of Debt | — | — | — | — | — | $0 | $0 | $2.5m | $600k | ($12.2m) | |
| Income Tax Expense (Benefit) | $36.7m | $36.0m | $18.8m | $22.9m | $102.1m | $83.5m | ($7.4m) | $29.3m | $47.7m | $30.2m | |
| Interest Expense Nonoperating | — | — | — | — | — | — | — | — | $71.0m | $59.3m | |
| Operating Lease, Lease Income | — | — | — | — | $30.5m | $62.1m | — | — | — | — | |
| Other Nonoperating Income (Expense) | $263k | ($815k) | $1.6m | $1.7m | $4.7m | ($3.7m) | ($11.7m) | $8.9m | $12.5m | $54.2m | |
| Changes in operating assets and liabilities: | |||||||||||
| Additional Financial Items | |||||||||||
| Increase (Decrease) in Accounts Receivable | $22.4m | $4.8m | $94.2m | $8.2m | ($49.0m) | $48.2m | ($118.1m) | $21.6m | $24.4m | ($25.5m) | |
| Increase (Decrease) in Inventories | $9.0m | ($6.1m) | $1.9m | $16.7m | $83.2m | $44.0m | $57.1m | ($600k) | $24.5m | $30.3m | |
| Increase (Decrease) in Accounts Payable | ($14.8m) | $16.1m | ($7.0m) | $16.5m | $19.8m | ($2.5m) | ($14.0m) | $10.6m | ($33.0m) | ($8.4m) | |
| Proceeds from Stock Options Exercised | $17.1m | $19.3m | $15.9m | $8.2m | — | $0 | $500k | $0 | $0 | $2.2m | |
| Goodwill | $41.0m | $49.1m | $259.7m | $266.6m | $266.7m | $224.9m | $218.2m | $0 | $0 | $0 | |
| Investment Income, Interest | $1.1m | $1.8m | — | — | — | — | — | — | — | — | |
| Nonoperating Income (Expense) | ($6.3m) | ($5.7m) | ($8.3m) | ($36.7m) | ($26.6m) | ($38.2m) | ($49.0m) | ($4.8m) | ($34.2m) | ($17.3m) | |
| Operating Costs and Expenses | — | — | — | — | $1.1b | $1.4b | $1.3b | $1.8b | $1.2b | $642.8m | |
| Operating Expenses | — | — | $692.6m | $991.9m | — | — | — | — | — | — | |
| Pension Cost (Reversal of Cost) | — | — | — | $1.0m | $2.4m | $2.0m | $800k | $600k | $0 | $0 | |
| Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement | — | — | — | — | ($1.0m) | $0 | $400k | $0 | — | — | |
| Net Cash Provided by (Used in) Operating Activities | $53.5m | $208.1m | $41.8m | $188.0m | $536.0m | $321.1m | ($34.1m) | ($206.3m) | $58.7m | $170.6m | |
| Cash flows from investing activities: | |||||||||||
| Payments to Acquire Property, Plant, and Equipment | $76.3m | $54.8m | $72.1m | $86.9m | $141.0m | $225.0m | $115.8m | $51.6m | $22.9m | $13.8m | |
| Payments to Acquire Businesses, Net of Cash Acquired | $0 | $195.1m | $827.7m | $0 | $0 | — | — | — | — | — | |
| Net Cash Provided by (Used in) Investing Activities | ($76.3m) | ($249.9m) | ($897.2m) | ($96.9m) | ($151.0m) | ($225.0m) | ($381.3m) | $212.3m | $125.2m | $69.4m | |
| Cash flows from financing activities: | |||||||||||
| Proceeds from Issuance of Long-term Debt | $0 | $0 | $798.0m | — | — | — | $0 | $0 | $219.0m | $0 | |
| Repayments of Long-term Debt | $0 | — | $2.8m | — | — | — | — | — | — | — | |
| Proceeds from Issuance of Common Stock | — | $19.3m | $15.9m | $8.2m | — | $0 | $0 | $8.4m | $0 | $0 | |
| Payments for Repurchase of Common Stock | $0 | $33.1m | $100k | $0 | $0 | $106.0m | $82.1m | $0 | $0 | $24.9m | |
| Net Cash Provided by (Used in) Financing Activities | ($19.8m) | ($51.4m) | $788.7m | ($35.9m) | $69.5m | ($141.0m) | $481.2m | ($535.7m) | ($190.0m) | ($136.6m) | |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $100k | $0 | ($200k) | $400k | ($1.0m) | ($300k) | $500k | ($1.2m) | $0 | $100k | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | $100k | $0 | ($200k) | $55.6m | $453.5m | ($45.2m) | $66.3m | ($530.9m) | ($6.1m) | $103.5m | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $100k | $0 | $112.4m | $168.0m | $621.5m | $576.3m | $642.6m | $111.7m | $105.6m | $209.1m | |
| Supplemental disclosure of cash flow information: | |||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating Activities | $8.2m | $8.4m | $10.2m | $34.5m | $21.0m | $30.4m | $33.0m | $68.3m | $64.0m | $49.7m | |
| Income Taxes Paid, Net | $10.1m | $12.0m | $14.0m | $30.8m | $109.3m | $71.6m | $6.2m | $52.8m | $26.5m | $40.0m |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.